belantamab mafodotin
Latest DREAMM Trial Suggests Potential Standard for Relapsed Multiple Myeloma
The most recent in a series of trials of multiple-drug combinations with the antibody-drug conjugate belantamab ...
JUNE 19, 2024
FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma
The FDA granted accelerated approval to belantamab mafodotin-blmf (Blenrep, GlaxoSmithKline) for adults with ...
AUGUST 12, 2020
Load more